Marc Verleye Selected Research

etifoxine

1/2019	Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization.
1/2016	Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.
5/2009	The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
12/2008	Etifoxine improves peripheral nerve regeneration and functional recovery.
5/2008	Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABA A-related mechanistic probes.
9/2006	Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
10/2002	Effects of etifoxine on ligand binding to GABA(A) receptors in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Verleye Research Topics

Disease

5	Seizures (Absence Seizure) 01/2022 - 10/2002
3	Anxiety Disorders (Anxiety Disorder) 12/2008 - 09/2006
2	Pain (Aches) 01/2019 - 01/2016
2	Hyperalgesia 01/2019 - 03/2011
2	Endotoxemia 04/2008 - 10/2007
2	Neuroblastoma 09/2006 - 07/2004
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Otitis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Edema (Dropsy) 01/2019
1	Brain Injuries (Brain Injury) 02/2016
1	Peripheral Nerve Injuries 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016
1	Neuroinflammatory Diseases 01/2016
1	Brain Edema (Cerebral Edema) 01/2016
1	Contusions 01/2016
1	Postoperative Pain 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Hypercholesterolemia 01/2014
1	Tremor (Tremors) 05/2009
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2009
1	Asthenia 01/2009
1	Fatigue 01/2009
1	Muscle Weakness 01/2009
1	Brain Ischemia (Cerebral Ischemia) 03/2007
1	Hypoxia (Hypoxemia) 03/2007
1	Ischemia 03/2007
1	Mood Disorders (Mood Disorder) 09/2006

Drug/Important Bio-Agent (IBA)

7	etifoxineIBA 01/2019 - 10/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 10/2002
3	Pharmaceutical PreparationsIBA 01/2016 - 09/2006
3	Nefopam (Ajan)IBA 01/2016 - 07/2004
3	LipopolysaccharidesIBA 01/2009 - 10/2007
2	stiripentolIBA 01/2022 - 02/2016
2	Neuroprotective AgentsIBA 01/2020 - 02/2016
2	CarrageenanIBA 01/2019 - 03/2011
2	NeurosteroidsIBA 01/2019 - 05/2008
2	Glutamic Acid (Glutamate)FDA Link 02/2016 - 03/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2016 - 03/2007
2	Analgesics (Analgesic Drugs)IBA 01/2016 - 03/2011
2	EndotoxinsIBA 01/2009 - 10/2007
2	Glutamate Receptors (Glutamate Receptor)IBA 03/2007 - 07/2004
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2022
1	GABA Agonists (GABA Receptor Agonists)IBA 01/2022
1	Pentylenetetrazole (Metrazol)IBA 01/2022
1	gaboxadol (THIP)IBA 01/2022
1	LigandsIBA 01/2020
1	BenzodiazepinesIBA 01/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	Oxygen (Dioxygen)IBA 02/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	CholesterolIBA 01/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2011
1	Ethanol (Ethyl Alcohol)IBA 05/2009
1	Diazepam (Valium)FDA LinkGeneric 05/2009
1	citrulline malateIBA 01/2009
1	Phosphorus (Red Phosphorus)IBA 01/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2008
1	tert-butylbicyclophosphorothionateIBA 05/2008
1	Adenosine Triphosphate (ATP)IBA 04/2008
1	GlycogenIBA 10/2007
1	Monoamine Oxidase (MAO)IBA 03/2007
1	Antidepressive Agents (Antidepressants)IBA 03/2007
1	Moclobemide (Arima)IBA 03/2007
1	Corticotropin-Releasing HormoneIBA 09/2006
1	VeratridineIBA 07/2004
1	N-Methylaspartate (NMDA)IBA 07/2004
1	MuscimolIBA 10/2002
1	PicrotoxinIBA 10/2002
1	Flunitrazepam (Rohypnol)IBA 10/2002

Therapy/Procedure

2	Analgesia 01/2019 - 01/2016
1	Intraperitoneal Injections 01/2009